Be aware of potential exclusions for weight loss or requirements like prior authorization, even if the drug is listed
Scientists continue to publish experimental findings exploring its biochemical mechanisms and molecular interactions
We proposed that this would apply to instances in which an ACO participant has undergone a CHOW resulting in a change to its Medicare enrolled TIN whereby the surviving Medicare enrolled TIN has no Medicare billing claims history
However, patients should be monitored clinically for pancreatitis, should pancreatitis occur, GLP-1RA should be stopped and not restarted due to risk of recurrence [185]
Contact your GP, healthcare provider, or if you need urgent advice NHS 111 if you experience: A persistent resting heart rate above 100 bpm (resting tachycardia) Palpitations a sensation of a racing, fluttering, or pounding heartbeat Dizziness, light-headedness, or near-fainting episodes Chest discomfort or tightness, particularly if associated with exertion Shortness of breath that is new or worsening Fatigue that is disproportionate to your level of activity Seek emergency medical attention (call 999 or go to A&E) if you experience: Chest pain radiating to the arm, jaw, or back Sudden severe breathlessness Loss of consciousness or collapse A very rapid or irregular heartbeat that does not settle within a few minutes Some symptoms, such as mild palpitations or a sensation of a faster heartbeat, may be transient and occur particularly after dose escalation
